123572-66-7

Usage

Uses

Used in Pharmaceutical Industry:
4-Fluoro-2-(trifluoromethoxy)aniline, 97% serves as a crucial intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties, contributing to advancements in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Fluoro-2-(trifluoromethoxy)aniline, 97% is utilized as an intermediate for the production of agrochemicals. Its incorporation can lead to the creation of novel compounds with improved pesticidal or herbicidal activity, enhancing crop protection strategies.
Used in Dye and Pigment Manufacturing:
4-Fluoro-2-(trifluoromethoxy)aniline, 97% is employed in the manufacturing of dyes and pigments due to its ability to impart color and stability. Its unique structure contributes to the development of dyes and pigments with specific characteristics, such as resistance to fading or improved solubility.
Used in Polymer Production:
4-Fluoro-2-(trifluoroMethoxy)aniline, 97% is also used in the production of polymers, where its distinctive chemical properties can influence the polymer's physical and chemical characteristics. This can lead to the development of polymers with enhanced properties for various applications.
Used in Material Science:
4-Fluoro-2-(trifluoromethoxy)aniline, 97% has potential applications in material science due to its unique chemical structure and properties. It can be used to develop new materials with specific characteristics, such as improved thermal stability, chemical resistance, or optical properties, broadening the scope of material applications.

Upstream product

• 123572-65-6 4-fluoro-1-nitro-2-(trifluoromethoxy)benzene 
• 1077-01-6 meta-fluoro(trifluoromethoxy)benzene 

Relevant academic research and scientific papers

2,4-DIAMINOPYRIMIDINE DERIVATIVES AS HISTAMINE H4 MODULATORS

The present invention relates to 2,4-diaminopyrimidines and pharmaceutically acceptable salts thereof, purification methods for the same, pharmaceutical compositions containing them, methods of obtaining and using them for the treatment of disease states,

EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF

A 4-substituted-2-(N-(5-substituted allyl amide)phenyl)amino)pyrimidine derivative as represented by formula (I), and a preparation and application thereof as an EGFR inhibitor. The compound has activity of inhibiting the L858R EGFR mutant, the T790M EGFR mutant and the exon 19 deletion activating mutant, may be used to treat diseases mediated alone or in part by EGFR mutant activity, and has a wide application in drugs preventing and treating cancers, particularly non-small cell lung cancer.

EGFR (Epidermal growth factor receptor) inhibitor and preparation method and use thereof

The present invention discloses an EGFR (Epidermal growth factor receptor) inhibitor and a preparation method and use thereof. In particular, the present invention relates to compounds of N-(5-((4-((2-(alkyl-substituted sulfonyl) pyridin-3-yl) amino) pyri

1-PHENYLPYRROLE COMPOUNDS

The present invention comprises a compound for the prevention and/or treatment of cardiovascular diseases, nephropathy, fibrosis, primary aldosteronism or edema. The compound is of the following general formula (I): wherein R1 represents a C1 -C3 alkyl group; R2 represents a hydroxy -C1 -C4 alkyl group and the like; R3 represents a halogeno group, a halogeno-C1 -C3 alkyl group and the like; R4 represents a hydrogen atom, a halogeno group and the like,- R5 represents a sulfamoyl group or a C1-C3 alkylsulf onyl group; R6 represents a hydrogen atom, a halogeno group and the like] or an N-oxide, atropisomer of the foregoing, or pharmaceutically acceptable salt of the foregoing.